Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Project Oncology®Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Brian P. McDonough, MD, FAAFP
Stacey Cohen, MD
Supporting Whole-Body Health Through the Gut
NutritionEdgeSupporting Whole-Body Health Through the Gut
Shelina Ramnarine, PhD
Terri DeNeui, DNP, APRN, ACNP-BC
Shared Decision-Making in Colorectal Cancer Screening
Clinician's RoundtableShared Decision-Making in Colorectal Cancer Screening
Gates B. Colbert, MD
Sarina Schrager, MD
Lashika Yogendran, MD
Breaking Barriers in Familial Chylomicronemia Syndrome
On the Frontlines of Familial Chylomicronemia SyndromeBreaking Barriers in Familial Chylomicronemia Syndrome
Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Robert Hegele MD, FRCPC
Irritable Bowel Syndrome with Constipation: Solving the Access and Adherence Puzzle
Clinician's RoundtableIrritable Bowel Syndrome with Constipation: Solving the Access and Adherence Puzzle
Brian P. McDonough, MD, FAAFP
Brooks D. Cash, MD
When to Adjust Treatment in Irritable Bowel Syndrome with Constipation
Clinician's RoundtableWhen to Adjust Treatment in Irritable Bowel Syndrome with Constipation
Brian P. McDonough, MD, FAAFP
Brooks D. Cash, MD
- advertisement
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
CME/CEIBD in Focus: A Case-Based Approach to Diagnosis and Assessment
David T. Rubin, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugonna Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
IBD Beyond Symptoms: What Community GIs Need to Know
MinuteCE®IBD Beyond Symptoms: What Community GIs Need to Know
David T. Rubin, MD
Ugonna Iroku, MD, MHS
Florence Odufalu, MD
Targeting Inflammation in IBD: Localized vs Systemic Strategies
MinuteCE®Targeting Inflammation in IBD: Localized vs Systemic Strategies
David T. Rubin, MD
Michael Dolinger, MD, MBA
Beyond Biology: Environmental and Lifestyle Influences in IBD
MinuteCE®Beyond Biology: Environmental and Lifestyle Influences in IBD
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Florence Odufalu, MD
- advertisement
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Charles Turck, PharmD, BCPS, BCCCP
Jun Gong, MD
Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Project Oncology®Harnessing the Immune Power: A Uniquely Designed PD-1 Inhibitor for Esophageal Cancer
Charles Turck, PharmD, BCPS, BCCCP
Jaffer Ajani, MD
Diagnosing IBS-C: From Clinical Clues to Confident Calls
Clinician's RoundtableDiagnosing IBS-C: From Clinical Clues to Confident Calls
Darren Brenner, MD
Kyle Staller, MD, MPH
An Expert’s Approach to a Difficult-to-Manage Condition: Breaking the rCDI Cycle with a Microbiome-Focused Strategy
Medical Industry FeatureAn Expert’s Approach to a Difficult-to-Manage Condition: Breaking the rCDI Cycle with a Microbiome-Focused Strategy
Paul Feuerstadt, MD, FACG, AGAF
Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Medical Industry FeatureRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
Joel Gabre, M.D, MPH
Pioneering a First in Robotic Liver Transplant
Medical Industry FeaturePioneering a First in Robotic Liver Transplant
Juan P. Rocca, M.D., MHA
- 05/29/2026
- 05/28/2026
- 05/27/2026
- 05/27/2026
- 05/25/2026
- 05/22/2026